Cytek Biosciences, Inc. CTKB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.23% | -0.01% | -1.28% | -5.88% | -5.78% |
| Total Receivables | -1.45% | -9.48% | 2.30% | 19.05% | 17.12% |
| Inventory | 3.01% | 6.35% | 10.38% | 10.56% | 10.78% |
| Prepaid Expenses | 2.17% | -19.29% | -12.09% | 4.79% | -9.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -43.10% | -18.67% | -34.05% | -62.36% | 5.80% |
| Total Current Assets | -2.46% | -1.28% | -0.32% | -1.12% | -0.44% |
|
|
|||||
| Total Current Assets | -2.46% | -1.28% | -0.32% | -1.12% | -0.44% |
| Net Property, Plant & Equipment | 5.95% | -8.57% | 12.31% | 4.24% | 2.00% |
| Long-term Investments | -0.04% | -0.10% | 0.07% | 0.20% | 3.18% |
| Goodwill | -0.04% | -0.10% | 0.07% | 0.20% | 3.18% |
| Total Other Intangibles | -20.64% | -20.08% | -19.18% | -16.43% | -13.74% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -86.55% | -85.37% | -87.17% | -86.62% | 20.87% |
| Total Assets | -9.85% | -9.40% | -6.94% | -7.60% | 0.75% |
|
|
|||||
| Total Accounts Payable | -35.98% | 22.69% | 7.91% | 15.93% | 41.62% |
| Total Accrued Expenses | 35.70% | 14.93% | 9.30% | 16.07% | 7.76% |
| Short-term Debt | 1,192.17% | 530.64% | 321.29% | 36.99% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -59.72% | -47.52% | -30.93% | -58.64% | 82.36% |
| Total Finance Division Other Current Liabilities | 10.27% | 6.42% | 14.02% | 15.65% | 10.88% |
| Total Other Current Liabilities | 10.27% | 6.42% | 14.02% | 15.65% | 10.88% |
| Total Current Liabilities | 12.96% | 15.10% | 19.57% | 14.99% | 19.76% |
|
|
|||||
| Total Current Liabilities | 12.96% | 15.10% | 19.57% | 14.99% | 19.76% |
| Long-Term Debt | -84.89% | -68.90% | -57.95% | -50.00% | -47.01% |
| Short-term Debt | 1,192.17% | 530.64% | 321.29% | 36.99% | -- |
| Capital Leases | -5.32% | -4.26% | 80.46% | 85.94% | 73.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.11% | -2.54% | -0.78% | -0.24% | -20.55% |
| Total Liabilities | 7.26% | 7.96% | 17.96% | 15.46% | 10.01% |
|
|
|||||
| Common Stock & APIC | 5.09% | 5.16% | 4.46% | 2.39% | 1.21% |
| Retained Earnings | -140.81% | -154.41% | -158.80% | -189.04% | -28.60% |
| Treasury Stock & Other | 221.44% | 7,307.89% | 489.00% | 13,906.25% | 712.87% |
| Total Common Equity | -15.11% | -14.73% | -13.69% | -13.64% | -1.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.11% | -14.73% | -13.69% | -13.64% | -1.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.11% | -14.73% | -13.69% | -13.64% | -1.79% |
|
|
|||||